ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,049.24
      0.88%
      US Tech 100
      21,108.40
      1.14%
      Dow Jones
      44,025.81
      1.24%
      Brent Oil
      78.615
      -0.17%
      Bitcoin
      105,788.22
      -0.36%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Bioventus Inc (BVS) Quote

      Bioventus Inc

      Bioventus Inc (BVS)

      Bravura Solutions Limited
      10.23
      0.19
      (1.89%)
      Closed January 21 4:00PM
      Delayed by 15 minutes
      10.23
      0.00
      (0.00%)
      After Hours: 4:00PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      10.23
      Bid
      10.07
      Ask
      10.85
      Volume
      289,589
      10.04 Day's Range 10.36
      3.90 52 Week Range 14.38
      Market Cap
      830.211M
      Previous Close
      10.04
      Open
      10.155
      Last Trade
      1
      @
      10.08
      Last Trade Time
      Financial Volume
      $ 2,958,778
      VWAP
      10.2172
      Average Volume (3m)
      377,639
      Shares Outstanding
      81,154,567
      Dividend Yield
      -
      PE Ratio
      -5.31
      Earnings Per Share (EPS)
      -1.93
      Revenue
      512.35M
      Net Profit
      -156.23M

      About Bioventus Inc

      Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, in... Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Show more

      Sector
      Surgical,med Instr,apparatus
      Industry
      Surgical,med Instr,apparatus
      Website
      www.bioventus.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Bioventus Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker BVS. The last closing price for Bioventus was $10.04. Over the last year, Bioventus shares have traded in a share price range of $ 3.90 to $ 14.38.

      Bioventus currently has 81,154,567 shares outstanding. The market capitalization of Bioventus is $814.79 million. Bioventus has a price to earnings ratio (PE ratio) of -5.31.

      Ask ADVFN Intelligence (AI)

      BVS Latest News

      More News

      FeaturedLuke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program

      10 hours ago

      Form 4 - Statement of changes in beneficial ownership of securities

      January 14 2025
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      January 13 2025
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      January 13 2025
      Edgar (US Regulatory)

      Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference

      DURHAM, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, chief executive officer, will...

      January 07 2025
      GlobeNewswire Inc.

      Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

      DURHAM, N.C., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has...

      January 02 2025
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      December 26 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 26 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      December 23 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      December 23 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      11.0511.43790849679.1810.258.773501999.71855328CS
      4-0.28-2.6641294005710.5111.088.773292059.95575609CS
      12-2.68-20.759101471712.9114.388.280337763911.23206325CS
      263.0542.47910863517.1814.386.200147462010.3574919CS
      525.41112.24066394.8214.383.93975598.47934557CS
      156-3.83-27.24039829314.0615.10.79994397865.12830915CS
      260-4.87-32.251655629115.119.94090.79993863116.47682529CS

      BVS - Frequently Asked Questions (FAQ)

      What is the current Bioventus share price?
      The current share price of Bioventus is $ 10.23
      How many Bioventus shares are in issue?
      Bioventus has 81,154,567 shares in issue
      What is the market cap of Bioventus?
      The market capitalisation of Bioventus is USD 814.79M
      What is the 1 year trading range for Bioventus share price?
      Bioventus has traded in the range of $ 3.90 to $ 14.38 during the past year
      What is the PE ratio of Bioventus?
      The price to earnings ratio of Bioventus is -5.31
      What is the cash to sales ratio of Bioventus?
      The cash to sales ratio of Bioventus is 1.62
      What is the reporting currency for Bioventus?
      Bioventus reports financial results in USD
      What is the latest annual turnover for Bioventus?
      The latest annual turnover of Bioventus is USD 512.35M
      What is the latest annual profit for Bioventus?
      The latest annual profit of Bioventus is USD -156.23M
      What is the registered address of Bioventus?
      The registered address for Bioventus is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Bioventus website address?
      The website address for Bioventus is www.bioventus.com
      Which industry sector does Bioventus operate in?
      Bioventus operates in the SURGICAL,MED INSTR,APPARATUS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ASSTAsset Entities Inc
      $ 0.8998
      (93.71%)
      		262.98M
      DWTXDogwood Therapeutics Inc
      $ 3.18
      (70.05%)
      		24.28M
      USEGUS Energy Corp
      $ 3.74
      (61.21%)
      		107.77M
      DOGZDogness International Corporation
      $ 27.62
      (52.60%)
      		1.93M
      MYNAMynaric AG
      $ 0.6697
      (50.83%)
      		3.72M
      GOEVCanoo Inc
      $ 0.3748
      (-72.24%)
      		41.46M
      SHOTWSafety Shot Inc
      $ 0.1094
      (-47.40%)
      		18.66k
      ORKTOrangeKloud Technology Inc
      $ 0.7068
      (-36.89%)
      		7.66M
      HEPAHepion Pharmaceuticals Inc
      $ 0.3219
      (-31.36%)
      		1.66M
      WNWMeiwu Technology Company Ltd
      $ 0.2681
      (-27.05%)
      		11.12M
      GCTKGlucoTrack Inc
      $ 0.1226
      (44.41%)
      		613.18M
      CRKNCrown Electrokinetics Corporation
      $ 0.1121
      (-10.32%)
      		392.52M
      ASSTAsset Entities Inc
      $ 0.8998
      (93.71%)
      		262.98M
      RIMEAlgorhythm Holdings Inc
      $ 0.034599
      (-16.83%)
      		230.08M
      RGTIRigetti Computing Inc
      $ 13.97
      (42.12%)
      		226.81M

      BVS Discussion

      View Posts
      Monksdream Monksdream 3 months ago
      BVS 10Q 11/5
      👍️0
      Monksdream Monksdream 3 months ago
      BVS anew 52 week high
      👍️0
      Monksdream Monksdream 5 months ago
      BVS new 52=high
      👍️0
      Monksdream Monksdream 5 months ago
      BVS new 52 week high
      👍️0
      Monksdream Monksdream 7 months ago
      BVS under $10
      👍️0
      tw0122 tw0122 9 months ago
      Durolane like it .. older news ..Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis

      Source: GlobeNewswire Inc.

      Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has agreed to a nationwide contract with Aetna™ Medicare Advantage plans. Beginning January 1, 2024, over 3 million Aetna™ Medicare Advantage plan members will have access to DUROLANE to treat knee osteoarthritis (OA) pain. DUROLANE, is a single-injection hyaluronic acid (HA)-based joint-fluid treatment for patients. DUROLANE will be one of two single-injection HA products under contract.
      OA involves the breakdown, or degeneration, of cartilage and the synovial fluid that cushions and lubricates joint tissues. Injection treatments of HA-based products, such as DUROLANE, help manage knee OA pain.

      “We are pleased DUROLANE is among the preferred options available to both Aetna™ Medicare Advantage members and physicians,” said Anthony Doyle, General Manager, Pain Treatments and Restorative Therapies for Bioventus. “Both now have access to a safe HA product that is proven to provide relief from knee OA pain.”

      About Bioventus

      Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

      👍️0
      TheFinalCD TheFinalCD 9 months ago
      https://twitter.com/MarketCurrents/status/1787801976102924503
      👍️0
      Monksdream Monksdream 9 months ago
      BVS under $5

      👍️0

      Your Recent History

      NASDAQ
      BVS
      Bioventus
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads